Copyright
©The Author(s) 2020.
World J Gastroenterol. Aug 28, 2020; 26(32): 4866-4877
Published online Aug 28, 2020. doi: 10.3748/wjg.v26.i32.4866
Published online Aug 28, 2020. doi: 10.3748/wjg.v26.i32.4866
Figure 1 Plasma dephosphorylated and uncarboxylated matrix Gla protein levels in inflammatory bowel disease patients and control group (A) and between patients with Crohn’s disease and ulcerative colitis (B).
aP < 0.001 vs control group; bP = 0.432 vs ulcerative colitis group. dp-ucMGP: Dephosphorylated and uncarboxylated matrix Gla protein.
- Citation: Brnic D, Martinovic D, Zivkovic PM, Tokic D, Vilovic M, Rusic D, Tadin Hadjina I, Libers C, Glumac S, Supe-Domic D, Tonkic A, Bozic J. Inactive matrix Gla protein is elevated in patients with inflammatory bowel disease. World J Gastroenterol 2020; 26(32): 4866-4877
- URL: https://www.wjgnet.com/1007-9327/full/v26/i32/4866.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i32.4866